DUAKLIR® PRESSAIR® (aclidinium bromide/formoterol fumarate inhalation powder) is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Limitations of Use: DUAKLIR PRESSAIR is not indicated for the relief of acute bronchospasm or for the treatment of asthma.
Clear Improvement in Lung Function
In 3 clinical trials (AMPLIFY, AUGMENT, ACLIFORM), DUAKLIR PRESSAIR demonstrated improvement in lung function. In the most recent trial, AMPLIFY, DUAKLIR PRESSAIR provided significant improvement in lung function forced expiratory volume in 1 second (FEV1) over time compared to its mono-components and tiotropium.2,3
Learn More About DUAKLIR EfficacyClear Feedback
PRESSAIR is a preloaded, dry powder inhaler that provides dual feedback—a visual cue (color-controlled window) and an audible "click"—that reassures patients of proper dose delivery.2,*
A "click" will sound when the patient is inhaling correctly
The color-controlled window changes from GREEN to RED when a patient has successfully inhaled the full dose
*Feedback mechanisms consist of visual cues
(color-controlled window) and an audible "click."
Note: some people may not hear the "click." Use
the control window to ensure you have inhaled correctly.
